Dergiler / Şişli Etfal Hastanesi Tıp Bülteni / 2021 / Cilt: 55 - Sayı: 1

Analysis of the Factors Affecting Survival in the Patients who Underwent Curative-Intent Gastrectomy due to Gastric Adenocarcinoma

Sayfa
23–32
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Splenec- tomy should be avoided in the absence of direct invasion of the tumour or metastasis of lymph nodes on splenic hilum to prevent postoperative infectious complication-related mortality.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: Gastric cancer is the fifth most common cancer and the third most common cause of cancer-related deaths in the world.
📊
Temel Bulgular & Veri:Methods: The medical records of 644 patients who underwent gastrectomy between January 2007 and January 2017 in our clinic were retrospectively reviewed.
💡
Sonuç & Katkı:Splenec- tomy should be avoided in the absence of direct invasion of the tumour or metastasis of lymph nodes on splenic hilum to prevent postoperative infectious complication-related mortality.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2007 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: Gastric cancer is the fifth most common cancer and the third most common cause of cancer-related deaths in the world. In this study, we aimed to evaluate the impact of clinicopathological factors on overall survival in the patients who under- went curative-intent gastrectomy due to gastric adenocarcinoma. Methods: The medical records of 644 patients who underwent gastrectomy between January 2007 and January 2017 in our clinic were retrospectively reviewed. Among these patients, 359 patients were included in this study. The impact of several prognostic factors on survival was investigated. Results: The mean age was 59.2±11.6 (29-83). Male/female ratio was 2.12. The median follow-up time was 19 months (CI=10.1- 31.1). Median overall survival was 23±2.3 months (CI=18.3-27.6). Splenectomy, R1 (microscopically incomplete) resection, and advanced stage were independent risk factors for poor prognosis. Conclusion: R1 resection, splenectomy, and advanced TNM stage were associated with poor prognosis in gastric cancer. Splenec- tomy should be avoided in the absence of direct invasion of the tumour or metastasis of lymph nodes on splenic hilum to prevent postoperative infectious complication-related mortality.

🔖

Bu Makaleye Atıf Yap

KARAİSLİ, S., GUR, E. O., OZSAY, O., CENGİZ, F., ER, A., ATAHAN, M. K., PEKER, Y., DİLEK, O. N., HACİYANLİ, M. (2021). Analysis of the Factors Affecting Survival in the Patients who Underwent Curative-Intent Gastrectomy due to Gastric Adenocarcinoma. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 55 - Sayı: 1, 23–32. https://ajindex.com/articles/402849

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87–108
  2. IARC. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012, 2015. Available at: http://glo- bocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Accessed Jan 23, 2020
  3. NCI. SEER Cancer statistics fact sheets: stomach cancer. (2020). Available at: http://seer.cancer.gov/statfacts/html/stomach.html. Accessed Aug 29, 2020
  4. Republic of Turkey Ministry of Health, Health statistics year- book 2015. Available at: https://dosyasb.saglik.gov.tr/Eklen- ti/6118,healthstatisticsyearbook2015pdf.pdf?0. Accessed Jan 23, 2020
  5. Türkiye İstatistik Kurumu, Ölüm nedeni istatistikleri - 2015. Avail- able at: http://www.tuik.gov.tr/PreTablo.do?alt_id=1083. Ac- cessed Dec 3, 2018
  6. WHO Classification of tumors of the digestive system. Lyon: IARC; 2010
  7. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestınal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31–49
  8. AJCC Cancer Staging Manual. In: Edge S, Byrd DR, Compton CC, Fritz AG, Greene F, Trotti A, editors. 7th ed. New York, NY: Springer; 2010. p. 117–26
  9. Russell MC, Hsu C, Mansfield PF. Primary gastric malignancies. In: Barry W, Feig MD, Denise C, Ching MD, editors. The MD Anderson surgical oncology handbook. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2012. p. 270–322
  10. Etoh T, Katai H, Fukagawa T, Sano T, Oda I, Gotoda T, et al. Treat- ment of early gastric cancer in the elderly patient: results of EMR and gastrectomy at a national referral center in Japan. Gastroin- test Endosc 2005;62:868–71
  11. Shim JH, Song KY, Kim HH, Han SU, Kim MC, Hyung WJ, et al. Signet ring cell histology is not an independent predictor of poor prognosis after curative resection for gastric cancer: a propensity analysis by the KLASS Group. Medicine (Baltimore) 2014;93:e136
  12. Liu X, Cai H, Sheng W, Yu L, Long Z, Shi Y, et al. Clinicopathological characteristics and survival outcomes of primary signet ring cell carcinoma in the stomach: retrospective analysis of single center database. PLoS One 2015;10:e0144420
  13. Liu K, Wan J, Bei Y, Chen X, Lu M. Prognostic Impact of different histological types on gastric adenocarcinoma: a surveillance, ep- idemiology, and end results database analysis. Pathol Oncol Res 2017;23:881–7
  14. Ahmad A, Khan H, Cholankeril G, K